Hikma Pharmaceuticals (HIK)

 

HIK Share PerformanceMore

52 week high2,703.0 02/08/16
52 week low1,575.0 16/03/16
52 week change -331.0 (-13.64%)
4 week volume10,915,098 30/08/16

Latest NewsMore

Director/PDMR Shareholding

RNS Number: 6023K Hikma Pharmaceuticals Plc 22 September 2016 Notification and public disclosure of transactions by persons discharging managerial responsibilities The attached individual notification made under article 19.1 of the Market Abuse Regulation (" MAR ") relates to the purchase by Darhold Limited of Ordinary Shares of 10 pence each in Hikma Ph...

Board appointment and succession

RNS Number: 2871K Hikma Pharmaceuticals Plc 20 September 2016 Board Appointment and Succession London, 20 September 2016 - Hikma Pharmaceuticals PLC (LSE: HIK) (DIFX: HIK) ( Hikma ), the fast growing pharmaceuticals company, is today announcing the following changes to its Board composition. Nina Henderson The Board is pleased to confirm that w...

Director/PDMR Shareholding

RNS Number: 1276K Hikma Pharmaceuticals Plc 16 September 2016 Notification and public disclosure of transactions by persons discharging managerial responsibilities The attached individual notification made under article 19.1 of the Market Abuse Regulation (" MAR ") relates to the purchase by Darhold Limited of Ordinary Shares of 10 pence each in Hikma Pha...

Director/PDMR Shareholding

RNS Number: 9924J Hikma Pharmaceuticals Plc 15 September 2016 Notification and public disclosure of transactions by persons discharging managerial responsibilities The attached individual notification made under article 19.1 of the Market Abuse Regulation (" MAR ") relates to the purchase by Darhold Limited of Ordinary Shares of 10 pence each in Hikma Pha...

Broker Forecast - JP Morgan Cazenove issues a broker note on Hikma Pharmaceuticals PLC

JP Morgan Cazenove today reaffirms its overweight investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and cu...

Broker Forecast - Jefferies International issues a broker note on Hikma Pharmaceuticals PLC

Jefferies International today reaffirms its buy investment rating on Hikma Pharmaceuticals PLC (LON:HIK) and cut its p...

Director/PDMR Shareholding

RNS Number: 3714J Hikma Pharmaceuticals Plc 08 September 2016 Notification and public disclosure of transactions by persons discharging managerial responsibilities The attached individual notification made under article 19.1 of the Market Abuse Regulation (" MAR ") relates to the purchase by Darhold Limited of Ordinary Shares of 10 pence each in Hikma Pha...

Director/PDMR Shareholding

RNS Number: 1294J Hikma Pharmaceuticals Plc 06 September 2016 Notification and public disclosure of transactions by persons discharging managerial responsibilities The attached individual notification made under article 19.1 of the Market Abuse Regulation (" MAR ") relates to the purchase by Darhold Limited of Ordinary Shares of 10 pence each in Hikma Pha...

Latest discussion posts More

  • Re: Management Buyout?

    For me, it's also a Weak BUY at the moment. We know WHAT they are buying, but we don't - or at least I don't - know WHY they are buying. Up till now, I've assumed that it's ...
    23-Sep-2016
    sapito
  • Re: Management Buyout?

    Directors taking the company back private would certainly help explain the recent large purchases; but I doubt it. It's only 10 years since it listed, and (without checking) I ...
    23-Sep-2016
    Hardboy
  • Management Buyout?

    More Diector buys here, thats another 3 buys since last week running into millions, something brewing for sure as they have nearly 30% accumulated, my guess is 2900p would be a ...
    22-Sep-2016
    Fred Prior

Users' HoldingsMore

Users who hold Hikma Pharmaceuticals also hold..
LLOYDS GRP.32%
GLAXOSMITHKLINE29%
RDS 'B'28%
VODAFONE GRP.24%
BP22%

Codes & Symbols

ISINGB00B0LCW083
SymbolsHIK, LSE:HIK, HIK.L, HIK:LN, LON:HIK, XLON:HIK